苯环己定
右美沙芬
滥用责任
右旋糖酐孤儿
美金刚
NMDA受体
药理学
氯胺酮
医学
心理学
麻醉
药品
内科学
受体
作者
Katherine L. Nicholson,Robert L. Balster
标识
DOI:10.1096/fasebj.24.1_supplement.765.9
摘要
Preclinical self‐administration (SA) procedures provide face validity and in may cases predictive validity regarding the abuse potential of drugs. A number of NMDA channel blocking antagonists are self‐administered off a fixed‐ratio (FR) phencyclidine (PCP) baseline. To assess relative abuse liability, the high affinity channel blockers PCP, ketamine and dextrorphan and the low affinity channel blockers memantine and dextromethorphan were re‐evaluated using a FR/progressive ratio (PR) procedure. Adult rhesus monkeys participated in daily 1‐h FR 20 SA sessions for 3 to 10 μg/kg/infusion PCP. Test drug solutions serving as positive reinforcers under the FR schedule were evaluated under a PR schedule in which the ratio for each infusion was increased by 10 or 20 (dependent on subject) during each subsequent session. One or more doses of all of the channel blockers, high affinity and low affinity, served as positive reinforcers of behavior under the FR schedule. Under a PR schedule, the high affinity compounds demonstrated much greater break points than the low affinity channel blockers, suggesting a higher reinforcing efficacy and abuse potential for the former compounds. Overall this approach appears to provide a refinement on previous substitution procedures for evaluating the abuse liability of NMDA antagonist drugs that is most predictive of human abuse potential. Supported by NIDA grant DA‐01442.
科研通智能强力驱动
Strongly Powered by AbleSci AI